Magainin 2
Frog-skin-derived antimicrobial peptide; parent of the pexiganan topical antibiotic.
Scientific Overview
Magainin 2 is a 23-aa cationic alpha-helical peptide isolated from the African clawed frog (Xenopus laevis) by Michael Zasloff in 1987. It forms toroidal pores in microbial membranes. Its analog pexiganan (MSI-78) was studied in two Phase 3 trials for diabetic foot ulcers but failed to meet superiority endpoints, leading to FDA non-approval.
Key Research Benefits
- ✓Broad-spectrum antibacterial
- ✓Antifungal activity
- ✓Membrane-pore mechanism
Potential Side Effects
Research Protocols
Common DosagesResearch
“Topical studies only”
Dose Calculator
🧮 Peptide Reconstitution Calculator
Total amount of peptide in the vial.
Volume of water used to mix.
Draw to this mark
or 0.10 mL on a U-100 syringe
Explore Magainin 2
Where to source
Vendors with public COAs that stock this category. Affiliate links are disclosed.
- Limitless Life NootropicsFL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.COA: JanoshikAffiliate disclosed
- SwissChems60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.COA: JanoshikAffiliate disclosed
- Amino ClubEU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.COA: Third-partyAffiliate disclosed
Molecular Profile
Quick Reference
- Status
- Research Compound
- Category
- Other
- Common Dosage
- Not established
- N/A
Strictly for research purposes. Not for human consumption.
Related tools
Medical Disclaimer
Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.